Literature DB >> 32501181

Rectosigmoid Endometriosis Vascular Patterns at Intraoperative Indocyanine Green Angiography and their Correlation with Clinicopathological Data.

Diego Raimondo1, Manuela Mastronardi1, Mohamed Mabrouk1,2,3, Gabriella Cafagna1, Paolo Salucci1, Alessandro Arena1, Raffaella Iodice1, Giulia Borghese1, Paolo Casadio1, Simona Del Forno1, Ilaria Giaquinto1, Giacomo Caprara4, Renato Seracchioli1.   

Abstract

Introduction. The objective of the study was to evaluate the presence of different rectosigmoid endometriosis (RSE) vascular patterns using intraoperative indocyanine green (ICG) angiography and their correlation with clinicopathological data. Material and Methods. A prospective pilot study on 30 consecutive symptomatic women affected by RSE and scheduled for minimally invasive surgery between May 2018 and January 2019. ICG was used for the intraoperative evaluation of RSE vascularization. Perfusion grade was classified as follows: 0-1 = no or low fluorescence (hypovascular pattern); 2 = regular fluorescence, similar to healthy surrounding rectosigmoid tract (isovascular pattern); and 3-4 = diffuse or abundant fluorescence (hypervascular pattern). Results. Thirty women were intravenously injected with ICG after nodule exposure. No adverse effects related to ICG use were noted. After a 5- to 50-s latency from ICG injection, the real-time direct visualization of RSE perfusion showed diffuse or abundant fluorescence in 12/30 (40%) women, while in the remaining 18/30 (60%), fluorescence was poor or absent. No statistical differences were observed between the 2 groups regarding preoperative, intraoperative, and histological variables analyzed, except for a maximum diameter of bowel lesions and microvessel density (MVD). Hypovascular nodules had a larger maximum diameter (39.5 ± 15.6 mm vs 30.3 ± 11.4 mm, P < .05) and lower MVD (154.6+/43.6 vs 281.1+/-77.4, P < .05) than hypervascular ones. Conclusions. ICG angiography is a feasible and safe technique to intraoperatively assess RSE vascularization. The majority (60%) of endometriotic nodule presented a hypovascular pattern. The hypovascular pattern seems to be associated with a larger nodule size and lower MVD.

Entities:  

Keywords:  indocyanine green; intraoperative near-infrared imaging; laparoscopy; rectosigmoid endometriosis; vascularization

Year:  2020        PMID: 32501181     DOI: 10.1177/1553350620930147

Source DB:  PubMed          Journal:  Surg Innov        ISSN: 1553-3506            Impact factor:   2.058


  4 in total

1.  Identification of Altered Evoked and Non-Evoked Responses in a Heterologous Mouse Model of Endometriosis-Associated Pain.

Authors:  Miguel A Tejada; Ana I Santos-Llamas; Lesley Escriva; Juan J Tarin; Antonio Cano; Maria J Fernández-Ramírez; Paulina Nunez-Badinez; Bianca De Leo; Philippa T K Saunders; Victor Vidal; Florent Barthas; Katy Vincent; Patrick J Sweeney; Rowland R Sillito; James Douglas Armstrong; Jens Nagel; Raúl Gomez
Journal:  Biomedicines       Date:  2022-02-21

2.  Role of Qualitative and Quantitative Indocyanine Green Angiography to Assess Mastectomy Skin Flaps Perfusion in Nipple/Skin-Sparing and Skin-Reducing Mastectomies with Implant-Based Breast Reconstruction.

Authors:  Manuela Mastronardi; Stefano Fracon; Serena Scomersi; Margherita Fezzi; Marina Bortul
Journal:  Breast J       Date:  2022-03-31       Impact factor: 2.269

3.  Antiangiogenic Therapy as a New Strategy in the Treatment of Endometriosis? The First Case Report.

Authors:  Jean Bouquet de Joliniere; Arrigo Fruscalzo; Fathi Khomsi; Emanuela Stochino Loi; Floryn Cherbanyk; Jean Marc Ayoubi; Anis Feki
Journal:  Front Surg       Date:  2021-12-06

Review 4.  The Use of near Infra-Red Radiation Imaging after Injection of Indocyanine Green (NIR-ICG) during Laparoscopic Treatment of Benign Gynecologic Conditions: Towards Minimalized Surgery. A Systematic Review of Literature.

Authors:  Antonio Raffone; Diego Raimondo; Alessia Oliviero; Arianna Raspollini; Antonio Travaglino; Marco Torella; Gaetano Riemma; Marco La Verde; Pasquale De Franciscis; Paolo Casadio; Renato Seracchioli; Antonio Mollo
Journal:  Medicina (Kaunas)       Date:  2022-06-13       Impact factor: 2.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.